SMA Capital »

Enliven Therapeutics shares owned by SMA Capital

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by SMA Capital from 13F filings

Historical chart of SMA Capital investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by SMA Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by SMA Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $10k 204 50.75

More positions owned by SMA Capital

Ametek (AME)
IDEX Corporation (IEX)
Parker-Hannifin Corporation (PH)
Johnson Controls Internation SHS (JCI)
CRH Ord (CRH)
Packaging Corporation of America (PKG)
J.B. Hunt Transport Services (JBHT)
Itt (ITT)
Teledyne Technologies Incorporated (TDY)
CSX Corporation (CSX)
Corteva (CTVA)
Ingersoll Rand (IR)
Amphenol Corp-cl A Cl A (APH)
Union Pacific Corporation (UNP)
Nordson Corporation (NDSN)

View all positions for SMA Capital

Top funds holding Enliven Therapeutics

OrbiMed Advisors
FMR
Polar Capital Holdings
BlackRock
Commodore Capital
Vestal Point Capital
Vanguard Capital Management
Bellevue Group
Citadel Advisors
Fairmount Funds Management
First Light Asset Management
Pictet Asset Management Holding SA
State Street Corporation
Geode Capital Management
Logos Global Management

View all funds holding Enliven Therapeutics